News

The Boston Beer Company SAM is navigating a complex inflection point where operating execution is improving even as consumer demand remains uneven. In a challenging macro backdrop marked by

Huntington Bancshares Incorporated HBAN is slated to report fourth-quarter and full-year 2025 results on Jan. 22, before the opening bell. The company’s quarterly revenues and earnings are expected

American Airlines Group Inc. (AAL) is scheduled to report fourth-quarter 2025 results on Jan. 27, before market open.

American Airlines has an encouraging earnings surprise history. The company’s

Teradyne TER and KLA Corporation KLAC are major players in the AI Infrastructure market. While Teradyne focuses on automated test equipment essential for validating high-performance AI chips, KLA

Owlet, Inc. OWLT is broadening its product ecosystem as part of a strategy to move beyond a single-device offering and address a wider set of infant monitoring needs. The company is expanding its

Ongoing public and private investment continues to underpin demand across the U.S. infrastructure construction landscape, with activity spanning transportation networks, utility systems, energy

DICK’S Sporting Goods, Inc. DKS delivered another solid performance in the third quarter of fiscal 2025. The company posted comparable sales (comps) growth of 5.7% for the DICK’S business in the

Rigetti Computing’s RGTI confidence in reaching a 1,000-plus qubit system by 2027 is increasingly anchored in its chiplet-based architecture rather than incremental lab optimism. Management made it

Fastenal Company FAST reported fourth-quarter 2025 results that came in line with the Zacks Consensus Estimate for both earnings and revenues, supported by steady contract customer momentum and

The renewable fuels industry is experiencing a structural transformation — from a commodity-based market toward a policy-backed, decarbonization-oriented energy sector, focusing more on low-carbon

Prologis PLD is slated to report its fourth-quarter 2025 results on Jan. 21, before the opening bell. In anticipation of the announcement, industry analysts and investors are eager to assess the

Strategy MSTR, the world’s largest corporate Bitcoin holder, has seen its stock decline 59.3% over the past six months, significantly underperforming both the Zacks Financial – Miscellaneous

FuelCell Energy FCEL is promoting its carbonate fuel cell technology as a practical response to a growing challenge in data center development: electricity demand is rising faster than what grid

Jabil, Inc. JBL is taking various initiatives to get a strong foothold in the expanding AI infrastructure space. The company is betting big on the AI data center market. The company’s innovation

McCormick & Company, Incorporated MKC is likely to witness growth in its top and bottom lines when it reports fourth-quarter 2025 earnings on Jan. 22, 2026. The Zacks Consensus Estimate for revenues

Coty Inc.’s COTY leadership is increasingly leaning on its innovation pipeline to reignite organic revenue growth, particularly as macro pressures weigh on discretionary beauty spending. In the

Comfort Systems USA, Inc. FIX is steadily expanding its exposure to data center construction, which is emerging as a meaningful driver of its accelerating growth profile. While the company continues

Pre-market futures are tumbling to start a new holiday-shortened trading week, generally on global economic concerns. Pick a direction, you’ll find something: Japanese bonds are falling on Prime

Box BOX shares have dropped 18.9% in the trailing 12-month period, underperforming the Zacks Internet Software industry’s decline of 2.3% and the broader Zacks Computer and Technology sector’s

Shares of Bloom Energy Corporation BE have gained 62.1% in the past month against the Zacks Alternative Energy - Other industry’s decline of 1.7%. The company has also outperformed the Zacks Oil &

Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of use of NEXPLANON (etonogestrel implant) 68 mg Radiopaque to up to five

Clover Health Investments CLOV is well poised for growth in the coming quarters, courtesy of its broad product spectrum. This optimism is primarily driven by its technology-first care model, as